drugset / Trial / NCT04372316

A Randomized Controlled Trial of Mecobalamin Injection and Tablet Treatment Efficacy on Mild to Moderate Diabetic Peripheral Neuropathy

NCT04372316

Phase 2 Unknown 30 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy of mecobalamin injection and tablet in the treatment of small fiber lesions in the early stage of diabetic peripheral neuropathy by corneal confocal microscopy.

Timeline

Start
2017-12-25
Primary completion
2020-07
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator methylcobalamin Small molecule 0.5 mg Intramuscular
Comparator methylcobalamin Small molecule 1.5 mg Intramuscular

Indications